Market Cap 1.68B
Revenue (ttm) 1.12B
Net Income (ttm) 440.30M
EPS (ttm) N/A
PE Ratio 204.20
Forward PE N/A
Profit Margin 39.19%
Debt to Equity Ratio -2.01
Volume 5,247,400
Avg Vol 4,672,920
Day's Range N/A - N/A
Shares Out 164.44M
Stochastic %K 47%
Beta 2.45
Analysts Sell
Price Target $14.11

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 268 2000
Address:
21 Firstfield Road, Gaithersburg, United States
Ctizzle
Ctizzle Jun. 5 at 1:01 PM
$NVAX what JJ thinks the Jefferies Healthcare Conference is about.
1 · Reply
Cheflokuaz
Cheflokuaz Jun. 5 at 12:39 PM
0 · Reply
Anik_ms
Anik_ms Jun. 5 at 12:18 PM
$NVAX anyone fresh ortexdata? Thank you :)
0 · Reply
Flo6
Flo6 Jun. 5 at 11:54 AM
$NVAX why red pm?
1 · Reply
DrFUShorts
DrFUShorts Jun. 5 at 11:41 AM
$NVAX You are basically inferring that all deals are already agreed upon but not yet disclosable. The ONLY hint Jacobs is giving US indirectly that we all should get EXCITED for is the 9,4M of bonus shares - a fair compensation for the mega deals they are going to ink but must remain confidential. Could be a good theory but... Or he could just being recycling for new investors: - top notch flu and CIC attracted investors but now they fell in to oblivion - crickets - presents C.Dif as the new blockbuster to attract New investors? What guarantees do we have that the fate of C.diff Will BE the same as flu and CIC vaccines?
2 · Reply
skiddy5
skiddy5 Jun. 5 at 11:30 AM
$GLSI execution becoming a concern. What was a crisp trial waiting on 14 events . Now trial expanded, now waiting for FDA to possibly change end point for a smaller number of events but not clear if and when? Drug and science works but this morphing into an unfocused monster.....giving off $NVAX vibes i've been there when these bio CEOs lose focus and start promising everything other than the simple outcome we all looking for.
0 · Reply
greko50
greko50 Jun. 5 at 11:08 AM
$NVAX You know what they say, when in doubt zoom out. 3 yr chart of NVAX. You can clearly see the bottom from the 2025 Apr tariff lows, to the slowly but surely higher lows and higher highs. Now just imagine what this chart will look like going forward 6, 12, 18 months from now, especially understanding the mc of 1.7 bil for Matrix M is peanuts 🥜. The last 2 Q's were better than expected, and the full transformation is still in the very early innings. With enough cash to last well into 2027 and possibly beyond, the risk/reward setup is highly favorable imo.....
1 · Reply
Paulchowda
Paulchowda Jun. 5 at 10:41 AM
$NVAX I see people trying to read between the lines with that conference yesterday, and all I have to say is stop, what are you really gonna break down in 30 minutes? This conference was unnecessary in a waste of money, I’m sure there was stuff after discussed, but come on give me a break. There’s nothing to read between the lines here. Not starting a debate everyone has their own opinion.
3 · Reply
CapitalMonk
CapitalMonk Jun. 5 at 10:11 AM
$NVAX Price: $10.19 (-0.10%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±2.64% RSI: 57.7 | Momentum: Moderate Volume: -15.6% vs avg Volatility: 5.24% Support: $8.64 | Resistance: $11.61 Data and analytics sourced from Given Analytics educational research: https://www.givenanalytics.com/
0 · Reply
truehealthvalue
truehealthvalue Jun. 5 at 10:09 AM
$NVAX I would look at $ELTX, About to take off, it will be worth billions in a short time
1 · Reply
Latest News on NVAX
Novavax Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 10:30 AM EDT - 22 hours ago

Novavax Transcript: Jefferies Global Healthcare Conference 2026


Novavax Slides: Corporate presentation

May 12, 2026, 7:00 AM EDT - 24 days ago

Novavax Slides: Corporate presentation


Novavax reports Q1 EPS (6c), consensus (23c)

2026-05-07T06:32:47.000Z - 4 weeks ago

Novavax reports Q1 EPS (6c), consensus (23c)


Novavax price target raised to $9 from $8 at TD Cowen

2026-05-07T05:08:24.000Z - 4 weeks ago

Novavax price target raised to $9 from $8 at TD Cowen

SNY


Novavax Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Novavax Earnings Call Transcript: Q1 2026


Novavax Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Novavax Quarterly report: Q1 2026


Novavax Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Novavax Earnings release: Q1 2026


Novavax Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Novavax Slides: Q1 2026


Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

Novavax Proxy statement: Proxy filing


Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

Novavax Proxy statement: Proxy filing


Novavax price target raised to $18 from $16 at B. Riley

2026-04-09T14:00:15.000Z - 2 months ago

Novavax price target raised to $18 from $16 at B. Riley


Novavax Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 3:40 PM EDT - 3 months ago

Novavax Transcript: Leerink Global Healthcare Conference 2026


Novavax Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 2:30 PM EST - 3 months ago

Novavax Transcript: TD Cowen 46th Annual Health Care Conference


Novavax price target raised to $8 from $7 at BofA

2026-02-27T15:25:36.000Z - 3 months ago

Novavax price target raised to $8 from $7 at BofA


Novavax price target raised to $7 from $6 at Citi

2026-02-27T11:45:11.000Z - 3 months ago

Novavax price target raised to $7 from $6 at Citi


Novavax to Participate in Upcoming Investor Conferences

Feb 26, 2026, 4:30 PM EST - 3 months ago

Novavax to Participate in Upcoming Investor Conferences


Novavax Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Novavax Earnings Call Transcript: Q4 2025


Novavax Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Novavax Earnings release: Q4 2025


Novavax Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Novavax Annual report: Q4 2025


Novavax Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Novavax Slides: Q4 2025


Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:15 AM EST - 4 months ago

Novavax Announces Entering into a License Agreement with Pfizer


Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 5 months ago

Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference


Novavax Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 11:30 AM EST - 7 months ago

Novavax Transcript: Jefferies London Healthcare Conference 2025


Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 4:41 PM EST - 7 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight


Novavax to Participate in Jefferies London Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 7 months ago

Novavax to Participate in Jefferies London Healthcare Conference


Novavax Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Novavax Earnings Call Transcript: Q3 2025


Novavax Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Novavax Earnings release: Q3 2025


Novavax Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Novavax Quarterly report: Q3 2025


Novavax Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Novavax Slides: Q3 2025


Novavax Announces Progress on Sanofi Agreement

Sep 30, 2025, 9:01 AM EDT - 8 months ago

Novavax Announces Progress on Sanofi Agreement


Novavax Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 10:20 AM EDT - 9 months ago

Novavax Transcript: Cantor Global Healthcare Conference 2025


Novavax Announces Convertible Debt Refinancing

Aug 21, 2025, 7:43 AM EDT - 10 months ago

Novavax Announces Convertible Debt Refinancing


Novavax Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 10 months ago

Novavax Earnings Call Transcript: Q2 2025


Novavax Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 10 months ago

Novavax Earnings release: Q2 2025


Novavax Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 10 months ago

Novavax Quarterly report: Q2 2025


Novavax Slides: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 10 months ago

Novavax Slides: Q2 2025


Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:08 AM EDT - 10 months ago

Novavax beats quarterly revenue estimates on milestone payment


Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

May 19, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA


U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 19, 2025, 7:00 AM EDT - 1 year ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine


FDA approves Novavax COVID vaccine with new conditions

May 17, 2025, 10:26 PM EDT - 1 year ago

FDA approves Novavax COVID vaccine with new conditions


Novavax Slides: FY 2025

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Slides: FY 2025


Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

May 8, 2025, 11:12 AM EDT - 1 year ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%


Novavax Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings Call Transcript: Q1 2025


Novavax Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings release: Q1 2025


Novavax Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Novavax Quarterly report: Q1 2025


Novavax Slides: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Novavax Slides: Q1 2025


Ctizzle
Ctizzle Jun. 5 at 1:01 PM
$NVAX what JJ thinks the Jefferies Healthcare Conference is about.
1 · Reply
Cheflokuaz
Cheflokuaz Jun. 5 at 12:39 PM
0 · Reply
Anik_ms
Anik_ms Jun. 5 at 12:18 PM
$NVAX anyone fresh ortexdata? Thank you :)
0 · Reply
Flo6
Flo6 Jun. 5 at 11:54 AM
$NVAX why red pm?
1 · Reply
DrFUShorts
DrFUShorts Jun. 5 at 11:41 AM
$NVAX You are basically inferring that all deals are already agreed upon but not yet disclosable. The ONLY hint Jacobs is giving US indirectly that we all should get EXCITED for is the 9,4M of bonus shares - a fair compensation for the mega deals they are going to ink but must remain confidential. Could be a good theory but... Or he could just being recycling for new investors: - top notch flu and CIC attracted investors but now they fell in to oblivion - crickets - presents C.Dif as the new blockbuster to attract New investors? What guarantees do we have that the fate of C.diff Will BE the same as flu and CIC vaccines?
2 · Reply
skiddy5
skiddy5 Jun. 5 at 11:30 AM
$GLSI execution becoming a concern. What was a crisp trial waiting on 14 events . Now trial expanded, now waiting for FDA to possibly change end point for a smaller number of events but not clear if and when? Drug and science works but this morphing into an unfocused monster.....giving off $NVAX vibes i've been there when these bio CEOs lose focus and start promising everything other than the simple outcome we all looking for.
0 · Reply
greko50
greko50 Jun. 5 at 11:08 AM
$NVAX You know what they say, when in doubt zoom out. 3 yr chart of NVAX. You can clearly see the bottom from the 2025 Apr tariff lows, to the slowly but surely higher lows and higher highs. Now just imagine what this chart will look like going forward 6, 12, 18 months from now, especially understanding the mc of 1.7 bil for Matrix M is peanuts 🥜. The last 2 Q's were better than expected, and the full transformation is still in the very early innings. With enough cash to last well into 2027 and possibly beyond, the risk/reward setup is highly favorable imo.....
1 · Reply
Paulchowda
Paulchowda Jun. 5 at 10:41 AM
$NVAX I see people trying to read between the lines with that conference yesterday, and all I have to say is stop, what are you really gonna break down in 30 minutes? This conference was unnecessary in a waste of money, I’m sure there was stuff after discussed, but come on give me a break. There’s nothing to read between the lines here. Not starting a debate everyone has their own opinion.
3 · Reply
CapitalMonk
CapitalMonk Jun. 5 at 10:11 AM
$NVAX Price: $10.19 (-0.10%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±2.64% RSI: 57.7 | Momentum: Moderate Volume: -15.6% vs avg Volatility: 5.24% Support: $8.64 | Resistance: $11.61 Data and analytics sourced from Given Analytics educational research: https://www.givenanalytics.com/
0 · Reply
truehealthvalue
truehealthvalue Jun. 5 at 10:09 AM
$NVAX I would look at $ELTX, About to take off, it will be worth billions in a short time
1 · Reply
Chelsea100
Chelsea100 Jun. 5 at 9:18 AM
$NVAX If you watch that conference, it felt more like a box-checking exercise than anything else. The important part is reading between the lines. Jacobs repeatedly emphasized that the business model is highly attractive: non-exclusive deals, upfront payments, milestones, and recurring economics from Matrix-M. On that point, I actually agree with him. What caught my attention was something else. The key person in that room wasn't Jacobs — it was Elaine. Jacobs looked like someone who has already done everything he can do. Sitting there, drinking his coffee, waiting. Not a man actively negotiating, but a man waiting for responses. My interpretation? The deals are likely already structured and largely agreed upon. What's missing may simply be the final approvals, signatures, and PR rollout. Could be wrong, but that's the impression I got from reading between the lines. $NVAX
2 · Reply
BTC321
BTC321 Jun. 5 at 9:09 AM
$NVAX i only vote yes if he comes up with a billion dollar deal until voting day
1 · Reply
Flo6
Flo6 Jun. 5 at 9:06 AM
$NVAX pls break at least 12 today 🙏
1 · Reply
DallasNV
DallasNV Jun. 5 at 8:12 AM
$NVAX JJ is a genius and the best thing that could have happened to Novavax. He has a plan. Just trust him. I would vote yes. Remember my words. 🤫
2 · Reply
Bodu
Bodu Jun. 5 at 8:07 AM
$NVAX Yesterday in Jeffries Novavax ( Ohara) stated 30 separated fields are now investigated by numerous pharmas including top 4 out of 10 big pharma. The new undisclosed big pharma partner who is also a world leader in oncology (no need to be genius to understand its Merck) is now testing matrix M with 9 different vaccines and treatments ( no need to be genius to understand at least part is oncology). What can i say. All these pharmas are not stupid and they don’t spend time and money for nothing. Matrix M will become the Intel inside. No doubt
0 · Reply
Benroxx
Benroxx Jun. 5 at 7:48 AM
$NVAX Why moon today?
0 · Reply
BTC321
BTC321 Jun. 5 at 6:11 AM
$NVAX BRAVO!!!
1 · Reply
GenZinvestor561
GenZinvestor561 Jun. 5 at 3:13 AM
$NVAX tf would vote for this 🖕🖕
0 · Reply
GenZinvestor561
GenZinvestor561 Jun. 5 at 3:12 AM
1 · Reply
dkallday
dkallday Jun. 5 at 2:18 AM
$NVAX directors want more money for doing nothing but trying to obtain partnerships F u novavax
0 · Reply
JB9696
JB9696 Jun. 5 at 1:30 AM
$NVAX seems like there's so much interest. Might as well held this in the men's room may have gotten more listeners
2 · Reply
JB9696
JB9696 Jun. 5 at 1:25 AM
$NVAX there's literally 1 guy in the room lol so fitting for the dream team.
1 · Reply